Food and Drug Administration Commissioner Marty Makary has reportedly committed to investigating the safety of the abortion drug mifepristone, according to The Hill.
In a letter, Makary told Sen. Josh Hawley, R-Mo., that the “FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of early pregnancy.”
“As the Commissioner of Food and Drugs, I am committed to conducting a review of mifepristone and working with the professional career scientists at the Agency who review this data,” he wrote, according to The Hill.
Read more at Newsmax© 2025 Newsmax. All rights reserved.
